|
Home : Unsafe Drugs : Avandia : Newsfeeds : Research and Markets: Hong Kong's Pharmaceuticals and Healthcare Market Should Reach HKD10.56bn (US$1.35bn) In Value at Consumer Prices By 2014 Research and Markets: Hong Kong's Pharmaceuticals and Healthcare Market Should Reach HKD10.56bn (US$1.35bn) In Value at Consumer Prices By 2014
In a related development, however, the Hong Kong Department of Health (DH) has recommended the restricted use of a diabetic drug containing rosiglitazone. This comes after the registration committee of the Pharmacy and Poisons Board asked doctors to stop ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




